ShareValue scores for KREBSBIO.NSE: Valuation 45, Quality 38, Growth 26, Health 29.

KREBSBIO.NSE
NSE

Krebs Biochemicals and Industries Limited

₹54.20(+0.15%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 15%
Valuation
45
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
26
Weak
Revenue & Earnings
Health
29
Stressed
Financial Stability
Momentum
43
Neutral
Price Trend

Company Details

About

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026